AARP Joins Three Lawsuits Against Large Drug Companies
New York Times (05/30/02) p.A17; Pear, Robert

Alleging that Bristol-Myers Squibb, Schering-Plough, and AstraZeneca deliberately kept prices high and avoided competition through "collusive agreements," AARP has joined three ongoing lawsuits and will seek monetary damages from the drug companies. AARP executive director William D. Novelli points out that Medicare is unlikely to continue in its current state if drug prices continue to increase. Pharmaceutical Research and Manufacturers of America spokesperson Jeffrey L. Trewhitt asserts that the lawsuits will not stop drug prices from rising.

Back   | Home   |  News Archive